𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patient with severe Crohn's disease became a father while on methotrexate and infliximab therapy

✍ Scribed by Francesca Lamboglia; Renata D'Incà; Lydia Oliva; Perla Bertomoro; Giacomo Carlo Sturniolo

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
55 KB
Volume
15
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe Legionella pneumophila pneumonia
Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease
✍ Florian Beigel; Matthias Jürgens; Levent Filik; Lutz Bader; Christian Lück; Burk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea

Effects of infliximab therapy on abdomin
Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease
✍ Erika Parmentier-Decrucq; Alain Duhamel; Olivier Ernst; Catherine Fermont; Alexa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132

Salmonella septic arthritis in a patient
Salmonella septic arthritis in a patient with Crohn's disease on infliximab
✍ Jean Y. Rim; Allan R. Tenorio 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of

Combined approach with infliximab, surge
Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study
✍ Pauline Roumeguère; Dominique Bouchard; François Pigot; Alain Castinel; Frederic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Background: Infliximab is the only medical therapy that has been proven to be effective in fistulizing Crohn's disease (CD), but the recurrence rate of fistulas is high despite maintenance therapy. The aim of this prospective study was to evaluate the short-and long-term efficacy of a combined sched

Splenic tuberculosis in a patient with C
Splenic tuberculosis in a patient with Crohn's disease on infliximab: Case report
✍ Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di V 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).